Sign In
Buy CRL
$232.51
-2.11 (-0.90%)
At Close: Jul 31, 2026
Charles River forecasts upbeat 2026 profit on improved demand for drug development services
07:54am, Wednesday, 18'th Feb 2026
Contract drug developer Charles River Laboratories on Wednesday forecast annual profit above Wall Street estimates, betting on an improvement in demand for its drug discovery and development services
Charles River Laboratories Announces Executive Appointments
07:01am, Wednesday, 18'th Feb 2026
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces Executive Appointments.
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
07:00am, Wednesday, 18'th Feb 2026
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance.
Aquestive Therapeutics: Biology Validated, Packaging Pending - A Forensic Analysis Of The Anaphylm CRL
03:15pm, Tuesday, 17'th Feb 2026
Aquestive Therapeutics: Biology Validated, Packaging Pending - A Forensic Analysis Of The Anaphylm CRL
What Analyst Projections for Key Metrics Reveal About Charles River (CRL) Q4 Earnings
10:16am, Monday, 16'th Feb 2026
Besides Wall Street's top-and-bottom-line estimates for Charles River (CRL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during th
What Moved Markets This Week
06:41am, Saturday, 14'th Feb 2026
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Here's How Charles River Stock Is Placed Ahead of Q4 Earnings
10:41am, Friday, 13'th Feb 2026
CRL heads into Q4 earnings with collaborations and strength in RMS and Manufacturing, even as DSA headwinds weigh on revenue expectations.
Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights
11:54am, Thursday, 12'th Feb 2026
Shareholders should contact the firm immediately as there may be limited time to enforce your rights Shareholders should contact the firm immediately as there may be limited time to enforce your right
Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for
11:01am, Wednesday, 11'th Feb 2026
Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chuck Royce's Strategic Moves: Significant Reduction in Haemonetics Corp
05:03pm, Monday, 09'th Feb 2026
Exploring the Fourth Quarter 2025 13F Filing Chuck Royce (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providing insigh
Penserra Capital Management LLC Makes New Investment in Charles River Laboratories International, Inc. $CRL
03:32am, Monday, 09'th Feb 2026
Penserra Capital Management LLC acquired a new position in shares of Charles River Laboratories International, Inc. (NYSE: CRL) during the undefined quarter, according to the company in its most recen
Universal Beteiligungs und Servicegesellschaft mbH Grows Stock Position in Charles River Laboratories International, Inc. $CRL
05:50am, Monday, 26'th Jan 2026
Universal Beteiligungs und Servicegesellschaft mbH increased its stake in shares of Charles River Laboratories International, Inc. (NYSE: CRL) by 154.0% in the undefined quarter, according to the comp
Charles River Laboratories International, Inc. $CRL Shares Acquired by Cooke & Bieler LP
05:10am, Monday, 26'th Jan 2026
Cooke and Bieler LP increased its stake in Charles River Laboratories International, Inc. (NYSE: CRL) by 0.9% during the undefined quarter, according to the company in its most recent Form 13F filing
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
04:30pm, Wednesday, 21'st Jan 2026
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call.
Charles River Enters Manufacturing Collaboration with Gazi University
08:00am, Wednesday, 21'st Jan 2026
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) and Gazi University Faculty of Medicine, today announced a gene therapy contract developme
